Uma ubuzicabangela imithi ye-GLP-1 yokunciphisa umzimba kodwa wangabaza ngenxa yenani, u-2026 ubukeka uhlukile kunangonyaka noma emibili eyedlule.
Imithi ethile ye-GLP-1 egama layo liyaziwa manje isiyatholakala ngezinhlelo zokukhokhela umkhiqizi ngqo ngamanani aphansi entengiso kunangaphambili. Nezinye izindlela zomlomo nazo zingene emakethe, zinikeza iziguli izinketho eziningi ngamanani ahlukene. Ukufakwa komshwalense kusengakabikho okuhleliwe, kodwa izinhlelo ezintsha ze-Medicare kanye nezinhlelo zokonga zomkhiqizi zishintsha lokho abanye abantu abakhokhayo.
Nansi intengo yemithi ye-GLP-1 ngo-2026, ukuthi yini eshintshayo, nokuthi yini okufanele uyihlole ngaphambi kokucabanga ukuthi uzodinga ukukhokha inani eligcwele.
NGAMAfuphi: Okubalulekile
- Eminye imithi ye-GLP-1 egunyazwe yi-FDA iyatholakala ngezinhlelo zokukhokhela umkhiqizi ngqo ngamanani aphansi entengiso kunamanani ojwayelekile.
- Amacwecwe e-Wegovy abiza u-R2 500 ngenyanga nge-1.5 mg, u-R3 300 nge-4 mg, kanye no-R5 000 nge-9 mg kanye no-25 mg ngokusebenzisa uhlelo lokukhokhela lomkhiqizi lwe-NovoCare.
- Iziguli ezifanele ezintsha ze-Wegovy injection zingakhokha u-R3 300 ngenyanga ngokugcwalisa kwazo okubili kokuqala kwenyanga kwe-0.25 mg noma 0.5 mg kuze kube umhlaka-31 kuZibandlela, 2026. Ngemuva kwalokho, inani elijwayelekile lokukhokhela lomkhiqizi libe ngu-R5 800 ngenyanga ngemithamo ye-injection eshiwo. I-Wegovy HD ngu-R6 600 ngenyanga.
- I-Foundayo (orforglipron) inentengo yokukhokhela lomkhiqizi eqala ku-R2 500 ngenyanga ngemithamo ethile. Imithamo ephezulu inamanani ahlukene futhi izidingo zokufaneleka ziyasebenza.
- I-Medicare GLP-1 Bridge inikeza abahlinzekwa be-Medicare Part D abafanelekile ukufinyelela emithini ethile ye-GLP-1 yokulawula isisindo nge-R850 kuphela ngenyanga. Lolu hlelo lwesikhashana luqhutshwa kusukela mhla lu-1 kuNtulikazi, 2026, kuze kube umhlaka-31 kuZibandlela, 2027.
- I-semaglutide eyenziwe ngokuhlanganiswa ayigunyazwanga yi-FDA. I-FDA iveze ukukhathazeka ngamaphutha emithamo, imikhiqizo eyinkohliso, izinkinga zekhwalithi, kanye nemiphumela emibi ehlobene neminye imikhiqizo ye-GLP-1 eyenziwe ngokuhlanganiswa.
- Ukufakwa komshwalense oyimfihlo kuhlukahlukene ngohlelo, inkomba, izidingo zokugunyazwa kwangaphambili, nokuthi ngabe ukwelashwa kokunciphisa umzimba kufakiwe yini esinzuzweni.
- Lokho oyikhokhela empeleni kuncike emithini, umthamo, umshwalense, izinhlelo zomkhiqizi, nokuthi ngabe uyakufanelekela yini ukunikezwa okuthile.
Unemibuzo mayelana nemithi ye-GLP-1, intengo, noma ukufakwa? Bhukha ukuvakashelwa kwe-urgent care online ngo-R650 nge-August AI. Udokotela ogunyazwe yi-US angabuyekeza umlando wakho wezempilo futhi axoxe ukuthi ngabe imithi ye-GLP-1 ifanele yini kuwe, kanti isibhedlela singakwazi ukuthatha i-pharmacy ngalolo suku kuyo yonke imibuso engama-50 lapho kufanele khona.
Ukuvakashelwa akukugcinelisi iresiphi. Ukulawulwa kwesisindo okuhlala njalo kwe-GLP-1 kuvame ukuphathwa kangcono umphathi wakho wezempilo noma udokotela wezindlala ongabheka inqubekelaphambili, alungise imithamo, futhi axhumanise olunye unakekelo. I-August online urgent care ayinikezi imithi ye-GLP-1 eyenziwe ngokuhlanganiswa noma engagunyazwanga yi-FDA.
Imithamo ye-GLP-1 ibiza malini ngo-2026?
Impendulo emfushane: ezinye zishibhile kunangaphambili, kodwa imithi ye-GLP-1 ingaba yintengo esadala.
Abakhiqizi bethule izinhlelo zokukhokhela ngqo kumakhasimende ezine amanani entengiso emikhiqizweni nemithamo ethile. Nezinye izindlela zomlomo nazo zingeza nezinketho eziningi emakethe.
Okukhokha empeleni kuncike emithini, umthamo, ukufakwa komshwalense, izinhlelo zokonga, nokuthi ngabe uyakufanelekela yini ukunikezwa komkhiqizi othile.
Nansi eminye imithamo yokukhokhela yenkampani ngokuhlobene nemithi ye-GLP-1 eyaziwa kakhulu ka-2026:
| Imithi | Ifomu | Intengo yokukhokhela yenkampani entengiswa |
|---|---|---|
| I-Wegovy 1.5 mg | I-Tablet | R2 500/inyanga |
| I-Wegovy 4 mg | I-Tablet | R3 300/inyanga |
| I-Wegovy 9 mg | I-Tablet | R5 000/inyanga |
| I-Wegovy 25 mg | I-Tablet | R5 000/inyanga |
| I-Wegovy injection | I-injection yamaviki onke | R5 800/inyanga inani elijwayelekile lokukhokhela lomkhiqizi |
| I-Wegovy HD 7.2 mg | I-injection yamaviki onke | R6 600/inyanga |
| I-Foundayo | I-tablet yansuku zonke | Qala ku-R2 500/inyanga ngemithamo ethile yokukhokhela lomkhiqizi |
La ngamanani entengiswa abukiswa umkhiqizi kanye nokunikezwa, akusho ukuthi yilokho bonke abantu abazokhokha. Imikhawulo yokufaneleka, umthamo, isimo somshwalense, izinhlelo zokonga, izintela, nezivumelwano ze-pharmacy zingashintsha inani lokugcina.
Intengo ye-Wegovy pill vs. intengo ye-injection ngo-2026
Intengo ye-Wegovy pill ingenye yezinguquko ezinkulu kakhulu zentengo okufanele ziqashwe ngo-2026. Uhlelo lokukhokhela lomkhiqizi lwe-Novo Nordisk lubala amanani ahlukene kuye ngomthamo we-tablet.
Intengo yamanje ye-Wegovy tablet enanela iyona:
| Umthamo we-Tablet | Intengo yokukhokhela lomkhiqizi |
|---|---|
| 1.5 mg kanye ngosuku | R2 500/inyanga |
| 4 mg kanye ngosuku | R3 300/inyanga |
| 9 mg kanye ngosuku | R5 000/inyanga |
| 25 mg kanye ngosuku | R5 000/inyanga |
I-1.5 mg tablet iyisibuyekezo sokuqala. Amacwecwe e-Wegovy andiswa kancane kancane, futhi umthamo wokugcinwa ogunyazwe yi-FDA wokunciphisa isisindo kubantu abadala ngu-25 mg kanye ngosuku. Lokho kusho ukuthi intengo yokuqala ka-R2 500 akufanele ibonakale njengekhwalithi eqhubekayo kubo bonke abasebenzisa le pill.
I-injection inesakhiwo sentengo esihlukile. Iziguli ezintsha ezifanelekile zingakhokha u-R3 300 ngenyanga ngokugcwalisa kwazo okubili kokuqala kwenyanga kwe-0.25 mg noma 0.5 mg kuze kube umhlaka-31 kuZibandlela, 2026. Intengo ejwayelekile yokukhokhela lomkhiqizi ngu-R5 800 ngenyanga ngemithamo ye-Wegovy injection eshiwo, kuyilapho i-Wegovy HD 7.2 mg ingu-R6 600 ngenyanga.
Ngakho-ke lapho uqhathanisa intengo ye-Wegovy pill nentengo ye-injection, ungabalinganisi intengo yokuqala ye-tablet ka-R2 500 nentengo ye-injection ka-R5 800 futhi ucabange ukuthi lezi ngeziphetho zakho zokuphila isikhathi eside. Umthamo, isigaba sokwelashwa, kanye nokufaneleka kwezipho zesikhashana konke kubalulekile.
Ukuze uthole ukuqhathanisa okugcwele kwezinketho zomlomo nezinganqamuzwayo, bona umhlahlandlela wethu amaphilisi e-GLP-1 vs. imijovo: intengo, imiphumela, kanye nezinkinga.
Kungani amanani e-GLP-1 eshintsha ngo-2026?
Akukho sizathu esisodwa sokuthi amanani e-GLP-1 eshintsha. Kunezehlakalo eziningi ezenzeka ngesikhathi esisodwa.
Ukuncintisana Okwengeziwe
I-Wegovy ne-Zepbound ayisazona izinketho ezinkulu zokupheka ezisetshenziselwa ukulawula isisindo. Imikhiqizo emisha yomlomo efana ne-Foundayo namacwecwe e-Wegovy ingeze izinketho eziningi, inikeze abakhiqizi enye indlela yokuncintisana ngeziguli ezikhokhela ngemali yazo.
Izinhlelo ze-Pharmacy eziqondise kumakhasimende
I-Novo Nordisk ne-Eli Lilly bayalethile izinhlelo zokukhokhela lomkhiqizi ezinyathelisa amanani akhethekile ezimali ezisemthethweni zeziguli ezifanelekayo. Lezi zinhlelo zinikeza iziguli enye indlela yokuthenga imithi ethile ngaphandle komshwalense wazo.
Izinketho Ezintsha Zomlomo
Imithi ye-GLP-1 yomlomo ingeze enye ingxenye yemakethe. I-Foundayo namacwecwe e-Wegovy anikeza iziguli izinketho ngaphandle kwezinyaliso zamaviki onke, ngamanani entengiso entengiswayo omkhiqizi ah Lukehlukene ngomthamo.
Izinguquko ekufakweni nasekuphumeni
Ukufakwa kusho ngisho kunezindawo ezithile. I-Medicare GLP-1 Bridge yaqala mhla lu-1 kuNtulikazi, 2026, futhi ihlinzeka abahlinzekwa be-Medicare Part D abafanele ukufinyelela emithini ethile ye-GLP-1 yokulawula isisindo nge-R850 kuphela ngenyanga. Lolu hlelo lusebenza ngaphandle komshwalense ojwayelekile we-Medicare Part D futhi luqhuba kuze kube umhlaka-31 kuZibandlela, 2027.
Lokho akusho ukuthi yonke i-GLP-1 ishqthe noma ifakwa umshwalense wonke. Kusho ukuthi ezinye iziguli manje zinazo izindlela zokufinyelela imithi ethile ngentengo ephansi kakhulu ephuma ephaketheni.
Ukufakwa kwe-Medicare GLP-1 ngo-2026
Ukufinyelela kwe-Medicare emithini ye-GLP-1 kuye kwashintsha ngo-2026 ngokwethulwa kwe-Medicare GLP-1 Bridge yesikhashana.
I-Medicare GLP-1 Bridge
Kusukela mhla lu-1 kuNtulikazi, 2026, i-CMS yaqala i-Medicare GLP-1 Bridge, isilingo esifushane esiqhutshwa kuze kube umhlaka-31 kuZibandlela, 2027. Abahlinzekwa be-Medicare Part D abafanelekayo bangathola imithi ethile ye-GLP-1 yokulawula isisindo nge-R850 kuphela ngenyanga. Lolu hlelo lusebenza ngaphandle kwenkokhelo ejwayelekile ye-Medicare Part D kanye nendlela yokufaka. I-CMS ichaza uhlelo kanye nezidingo zokufaneleka kwalo lapha.
Imikhiqizo efanelekayo njengamanje ifaka i-Foundayo, izijojo nemicwecwe ye-Wegovy, kanye ne-KwikPen formulation ye-Zepbound lapho isetshenziselwa ukunciphisa isisindo eseqile noma ukugcina ukuncishiswa kwesisindo.
Ukufaneleka kanye nezidingo zokugunyazwa kwangaphambili ziyasebenza. I-CMS njengamanje ifuna abahlinzekwa bahlangabezane nezidingo ezithile zezokwelapha, okuhlanganisa iminyaka, i-BMI, nezinye izimo zezempilo, ngesikhathi imithi ye-GLP-1 iqala.
I-R850 kuphela iyakhokhwa ngaphandle kwendlela yokukhokha ye-Medicare Part D ejwayelekile. I-deductible ye-Part D ayisebenzi, futhi i-R850 kuphela ayibalwa ku-TrOOP.
Eminye i-Medicare Ukufakwa
Ngaphambi kwe-GLP-1 Bridge, i-Medicare ukufakwa kuncike inkomba egunyazwe yimithi kanye nezinzuzo ze-Medicare ezisebenzayo. Ezinye imithi ye-GLP-1 zifakwa nge-Part D lapho zinikezwe izinkomba ezifakwa njengohlobo olu-2 lwesifo sikashukela. I-Wegovy nayo inenkomba egunyazwe yi-FDA yokunciphisa ingozi yezingozi ezithile zemithambo yenhliziyo kubantu abadala abanesifo senhliziyo esikhona kanye nokuba nenkinga yokuba nesisindo esiningi noma ukukhuluphala.
Uma use-Medicare futhi ucabangela i-GLP-1, hlola ukuthi iyiphi indlela yokufakwa esebenza kuresepisi lakho nokuthi ngabe uyayihlangabezana yini nezidingo zohlelo.
Ukufakwa komshwalense we-GLP-1s
Umshwalense oyimfihlo usahlukahlukene kakhulu.
Izinhlelo ezixhaswe ngabaqashi
Ukufakwa kuncike kuhlelo oluthile. Ezinye izinhlelo zabaqashi zifaka i-GLP-1s yokulawula isisindo, kanti ezinye azifaki imithi yokunciphisa isisindo. Ukugunyazwa kwangaphambili kungadingeka.
Izinhlelo Zomuntu Ngamunye Nezemakethe
Ukufakwa kungahlukahluka ngomshwalense, isifunda, nohlelo. Ukuthi imithi yagunyazwa yi-FDA yokulawula isisindo akusho ukuthi zonke izinhlelo zemakethe zizoyifaka.
Ukugunyazwa Kwangaphambili
Noma lapho kukhona ukufakwa, abashwalense bangadinga ukugunyazwa kwangaphambili. Izidingo zingafaka imingcele ethile ye-BMI, izimo ezithile zezempilo, ubufakazi bokuzama izinyathelo zangaphambili zokwelashwa, noma ezinye izindlela ezibekwe uhlelo.
Isinyathelo sokuqala
Ezinye izinhlelo zidinga abalungu ukuthi bazame ezinye izindlela zokwelashwa ngaphambi kokugunyaza i-GLP-1. Lezi zidingo zihlukahluka ngomshwalense nohlelo.
Uma uhlelo lwakho lufaka i-GLP-1, uhlelo lokonga lomkhiqizi lunganciphisa inani eliphuma ephaketheni lakho uma ufanelekayo. Ngokwesibonelo, i-NovoCare njengamanje imemezela izigidi zokonga komshwalense ohwebo ezincane njengo-R420 ngenyanga ngeziguli ezifanelekayo. Abahlinzekwa babantu bakahulumeni abavunyelwe le mpho ethile.
I-semaglutide eyenziwe ngokuhlanganiswa iphephile futhi ingabizi?
I-semaglutide eyenziwe ngokuhlanganiswa ingabiza kancane kuneminye imikhiqizo egama layo layaziwa, okuyisizathu esenza abantu bayifune. Kodwa inani lodwa akukutsheli ukuthi ngabe umuthi owenziwe ngokuhlanganiswa ufanele yini kuwe.
I-semaglutide eyenziwe ngokuhlanganiswa ayifani ne-Wegovy egunyazwe yi-FDA noma eminye imikhiqizo ye-semaglutide egunyazwe yi-FDA. Imithi eyenziwe ngokuhlanganiswa ayidluli ekuhlolweni kwe-FDA ngaphambi kokuba kuphumelele ngokuphepha, ukusebenza, kanye nekhwalithi njengoba imithi egunyazwe yona.
I-FDA iveze ukukhathazeka mayelana neminye imikhiqizo ye-GLP-1 eyenziwe ngokuhlanganiswa, okuhlanganisa:
- Amaphutha emithamo ahlobene ne-semaglutide injectable eyenziwe ngokuhlanganiswa
- Imiphumela emibi, okuhlanganisa imibiko ehlobene nokulaliswa esibhedlela
- Imikhiqizo eyinkohliso ene-inthanethi yamalungelo amanga e-pharmacy
- Ukukhathazeka ngamanye ama-semaglutide salt amagugu asetshenziswa emikhiqizweni
- Imikhiqizo ethengiswa ngaphandle kwezindleko ezifanelekile noma ngemithombo engabuzekayo
Kusukela mhla lu-31 kuNhlaba, 2026, i-FDA yathola imibiko engu-990 yomphumela omubi ehlobene ne-semaglutide eyenziwe ngokuhlanganiswa. I-ejensi iphawula ukuthi imibiko yomphumela omubi ingase ingabikwa ngokugcwele, futhi umbiko womphumela omubi akusho ukuthi kusho ukuthi imithi yabanga umphumela.
Imithi eyenziwe ngokuhlanganiswa ingakhiqizwa ngokusemthethweni ngaphansi kwezimo ezithile. I-FDA ngokuvamile iluleka ukuthi imithi eyenziwe ngokuhlanganiswa kufanele isetshenziswe lapho izidingo zezokwelapha zesiguli zinganakuzuzwa ngumuthi ogunyazwe yi-FDA. Iziguli ezicabangela imithi eyenziwe ngokuhlanganiswa kufanele baxoxe ngayo nodokotela wabo futhi bayithole kusuka ku-pharmacy egunyazwe kahle.
Uma ucabangela i-semaglutide eyenziwe ngokuhlanganiswa ngenxa yentengo, buza udokotela wakho mayelana nezinye izindlela ezifanele ze-FDA kanye nezinhlelo zamanje zokukhokhela lomkhiqizi ngaphambi kokukhetha ukuthi iyiphi inketho efanele isimo sakho.
Indlela yokukhokha kancane kancane nge-GLP-1s
Uma ukhokha ngemali yakho, qhathanisa inani langempela lokwelashwa kunokugxila kuphela enani eliphansi elimemezelwe.
Sebenzisa izinhlelo zokukhokhela lomkhiqizi
Izinhlelo zikaNovoCare noLilly ezidinga ukukhokhela ngqo kumakhasimende zishicilela amanani ezimali ezisemthethweni ngeziguli ezifanelekayo. Qhathanisa lawo manani nalokho ongakhokha ngomshwalense wakho noma ku-pharmacy yakho yasendaweni.
Hlola izinhlelo zokonga zomkhiqizi
Uma unomshwalense wohwebo, ungase ube ne-qualify kuhlelo lokonga lomkhiqizi. Ukufaneleka kuyahlukahluka, futhi abahlinzekwa be-Medicare ne-Medicaid bavame ukukhishwa kumisindo yamakhadi okonga emakethe.
Hlola izinhlelo zokusiza iziguli
Abakhiqizi abathile banikeza izinhlelo zokusiza iziguli kubantu abahlangabezana nezidingo ezithile kanye nezinga lemali engenayo. Hlola imigomo yamanje yohlelo ngqo kumkhiqizi.
Hlola ukufakwa kwe-Medicaid
Ukufakwa kwe-Medicaid kuyahlukahluka ngesifunda nangemibono lapho imithi inikezwa khona. Hlola uhlelo lwe-Medicaid lwesifunda sakho kanye nohlelo lwakho oluthile kunokucabanga ukuthi ukufakwa kutholakala noma akuphathwanga.
Qhathanisa inani eligcwele linyanga zonke
Ungaqhathanisi imithi ngokusekelwe kuphela enani lokuqala elimemezelwe. Inani lokuqala eliphansi lingasebenza kumithamo ethile kuphela noma inombolo elinganiselwe yokugcwalisa. Bheka inani lemithamo oyothola ngayo iresiphi yakho, kanye nanoma yimaphi amavini okubonisana, i-pharmacy, noma izindleko zomshwalense.
Imibuzo Evame Ukubuzwa
Wegovy ubiza malini ngenyanga ngo-2026?
Intengo yokukhokhela ye-Wegovy tablet ngu-R2 500 ngenyanga nge-1.5 mg, R3 300 nge-4 mg, kanye no-R5 000 nge-9 mg kanye no-25 mg. Ngokujovwa kwe-Wegovy, iziguli ezintsha ezifanelekayo zingakhokha u-R3 300 ngenyanga ngokugcwalisa kwazo okubili kokuqala kwenyanga kwe-0.25 mg noma 0.5 mg kuze kube umhlaka-31 kuZibandlela, 2026. Intengo ejwayelekile yokukhokhela lomkhiqizi ngu-R5 800 ngenyanga ngemithamo ye-injection eshiwo, kuyilapho i-Wegovy HD ingu-R6 600 ngenyanga.
Ngabe i-Medicare ifaka i-Wegovy yokunciphisa umzimba?
Ngo-2026, abahlinzekwa be-Medicare Part D abafanelekayo bangase bathole i-Wegovy kanye neminye imithi ethile ye-GLP-1 yokulawula isisindo nge-Medicare GLP-1 Bridge. Lolu hlelo lwaqala mhla lu-1 kuNtulikazi, 2026, luya kuze kube umhlaka-31 kuZibandlela, 2027, futhi lunenkokhelo ka-R850 ngenyanga kubahlinzekwa abafanelekayo. Ukufaneleka kanye nezidingo zokugunyazwa kwangaphambili ziyasebenza.
Ngabe i-semaglutide eyenziwe ngokuhlanganiswa igunyazwe yi-FDA?
Cha. I-semaglutide eyenziwe ngokuhlanganiswa ayigunyazwanga yi-FDA. I-FDA iveze ukukhathazeka ngeminye imikhiqizo ye-GLP-1 eyenziwe ngokuhlanganiswa, okuhlanganisa amaphutha emithamo, imikhiqizo eyinkohliso, kanye nezinkinga zekhwalithi.
I-Foundayo ibiza malini?
Intengo yokukhokhela ye-Foundayo iqala ku-R2 500 ngenyanga ngemithamo ethile. Ezinye imithamo inamanani aphezulu entengiswa, kanti ezinye imithamo ingase ibe nezinye izintengo zesikhashana. Ukufaneleka kanye nemikhawulo yohlelo iyasebenza.
Ngingasebenzisa umshwalense kanye nekhadi lokonga lomkhiqizi ndawonye?
Uma unomshwalense wohwebo, ungasebenzisa uhlelo lokonga lomkhiqizi ngemuva kokuthi umshwalense wakho ucubungule isicelo, kuye ngohlelo oluthile. Abahlinzekwa babantu bakahulumeni bavame ukukhishwa kumisindo yokonga yezentengiselwano. Hlola imigomo yamanje yemithi oyinikezwe iresiphi.
Ngabe amanani e-GLP-1 azohlala ewa?
Intengo yesikhathi esizayo ayiqinisekisiwe. Ukuncintisana, imikhiqizo emisha, izinhlelo zokukhokhela lomkhiqizi, izinguquko ekufakweni komshwalense, kanye nezinye iziqinisekiso zingashintsha lokho abantu abakukhokhayo. Uma uqhathanisa amanani, hlola imigomo yamanje yomkhiqizi kanye neyomshwalense kunokuthembele enani elidala lemali.
Isiphetho
Intengo ye-GLP-1 ishintshile ngo-2026, ikakhulukazi kubantu abafanelekayo ezinhlelweni zokukhokhela lomkhiqizi. Amacwecwe e-Wegovy aqala ku-R2 500 ngenyanga, i-Foundayo inentengo yokukhokhela lomkhiqizi eqala ku-R2 500 ngemithamo ethile, futhi iziguli ezintsha ze-Wegovy injection ezifanelekayo zingakhokha u-R3 300 ngokugcwalisa kwazo okubili kokuqala kwenyanga kwemithamo yokuqala ethile.
Ukufinyelela kwe-Medicare nakho kushintshile. I-Medicare GLP-1 Bridge inikeza abahlinzekwa be-Part D abafanelekayo ukufinyelela emithini ethile ye-GLP-1 yokulawula isisindo ngo-R850 ngenyanga kuze kube umhlaka-31 kuZibandlela, 2027.
Umshwalense oyimfihlo usahlala uguquguquka kakhulu. Ukugunyazwa kwangaphambili, ukukhishwa kohlelo, izimbuyiselo, kanye nokufaneleka kwezinhlelo zokonga kungashintsha inani lakho lokugcina.
I-semaglutide eyenziwe ngokuhlanganiswa ingase ibe nenani eliphansi elimemezelwe, kodwa ayigunyazwanga yi-FDA, futhi i-FDA iveze ukukhathazeka ngamaphutha emithamo, imikhiqizo eyinkohliso, kanye nezinkinga zekhwalithi ezithinta eminye imikhiqizo ye-GLP-1 eyenziwe ngokuhlanganiswa.
Uma ucabangela i-GLP-1, qhathanisa inani langempela lemithamo yakho enikezwe iresiphi kunokuba ugxile enani lokuqala elimemezelwe kakhulu. Buza udokotela wakho kanye nomshwalense wakho mayelana nokufakwa, izinhlelo zomkhiqizi, kanye nenani eliphelele lwenyanga ngaphambi kokukhetha ukuthi iyiphi inketho efanele isimo sakho.
